Indications for human papillomavirus vaccination programs are expanding to boys.
However, the rationale behind their inclusion is often not clear. Using a Bayesian synthesis …

F ull-page advertisements inviting parents to immunize their preadolescent boys against
human papillomavirus (HPV) have rekindled the debate over who should receive the world's …

Published data to date indicate that human papillomavirus (HPV) prevention vaccines are
safe and efficacious in reducing HPV persistence and cervical intraepithelial neoplasia …

The science of the newly approved prophylactic human papillomavirus (HPV) vaccines is
clear: vaccination of young women prevents genital type-specific infection with HPV 16 and …

Objective To assess the reduction in the vaccine preventable burden of cancer in men if
boys are vaccinated along with girls against oncogenic human papillomavirus (HPV) …

Registry-based effectiveness studies provide evidence for the real-world impact of the
human papillomavirus (HPV) vaccine. Given the length of time between acquisition of a …

Introduction HPV is the most common sexually transmitted disease in the United States, the
principal cause for cervical cancer, and the principal cause for the recent increase in head …

“What I soon found was that a lot of the decisions end up getting made by the treasurer,” said
Brown. Evidence is beginning to emerge, however, that the upfront cost of immunization may …

The quadrivalent HPV vaccine (HPV4) is safe and highly efficacious, and can significantly
reduce the burden of HPV-related genital warts and cancers among men, in addition to …

Human papillomavirus (HPV) vaccination rates for preadolescent and adolescent girls in the
United States are far behind those of other developed nations. These rates differ …